Corrigendum: Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults
Adarsh Raja, Rabia Asim, Muhammad Hamza Shuja, Sandesh Raja, Tazheen Saleh Muhammad, Simran Bajaj, Abdul Hadi Ansari, Hamza Ali, Iffat Ambreen Magsi, Muhammad Hammad Faridi, Hamza Ali Hasnain Sheikh, Muhammad Junaid Imran, Muhammad Ahmed, Muhammad Sohaib Asghar
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMigraine and Headache Studies
In the published article, there was an error. Two reviewer comments inadvertently appeared in the final published article. Two sentences have been removed from the Results section, Secondary outcomes. These sentences previously stated:
Regarding change in monthly headache days, I do not see the relevance to do a sensitivity analysis. Also after excluding Ailani et al., the mean value with 95% CI does not appear so different than the previous one.
A sentence has been removed from the Results section, Meta-regression, first paragraph. This sentence previously stated:
The meta-regression is not anticipated in the statistical analysis plan. What is the purpose of such analysis?
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.